Nuvo Pharms Drug Patent Portfolio
Nuvo Pharms owns 2 orange book drugs protected by 6 US patents Given below is the list of Nuvo Pharms's drug patents along with their expiration dates.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US7132570 | Method for the production of crystalline forms and crystalline forms of optical enantiomers of modafinil | 18 Jun, 2024 | Expired |
US7297346 | Pharmaceutical formulations of modafinil | 29 May, 2024 | Expired |
US7132570 | Method for the production of crystalline forms and crystalline forms of optical enantiomers of modafinil | 18 Dec, 2023 | Expired |
US7297346 | Pharmaceutical formulations of modafinil | 29 Nov, 2023 | Expired |
USRE37516 | Acetamide derivative having defined particle size | 06 Apr, 2015 | Expired |
USRE37516 | Acetamide derivative having defined particle size | 06 Oct, 2014 | Expired |
Latest Legal Activities on Nuvo Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Nuvo Pharms.
Activity | Date | Patent Number |
---|---|---|
![]() | ||
Expire Patent
Critical
| 23 Dec, 2019 | US7297346 (Litigated) |
Maintenance Fee Reminder Mailed
Critical
| 08 Jul, 2019 | US7297346 (Litigated) |
Expire Patent
Critical
| 10 Dec, 2018 | US7132570 |
Maintenance Fee Reminder Mailed
Critical
| 18 Jun, 2018 | US7132570 |
Correspondence Address Change
Critical
| 05 Jan, 2010 | US7132570 |
Recordation of Patent Grant Mailed
Critical
| 20 Nov, 2007 | US7297346 (Litigated) |
Patent Issue Date Used in PTA Calculation
Critical
| 20 Nov, 2007 | US7297346 (Litigated) |
Issue Notification Mailed
Critical
| 31 Oct, 2007 | US7297346 (Litigated) |
Application Is Considered Ready for Issue
Critical
| 16 Oct, 2007 | US7297346 (Litigated) |
Dispatch to FDC | 16 Oct, 2007 | US7297346 (Litigated) |
Issue Fee Payment Received
Critical
| 05 Oct, 2007 | US7297346 (Litigated) |
Issue Fee Payment Verified
Critical
| 05 Oct, 2007 | US7297346 (Litigated) |
Mail Miscellaneous Communication to Applicant | 31 Aug, 2007 | US7297346 (Litigated) |
Printer Rush- No mailing | 31 Aug, 2007 | US7297346 (Litigated) |
Miscellaneous Communication to Applicant - No Action Count | 30 Aug, 2007 | US7297346 (Litigated) |
Nuvo Pharms's Family Patents

Nuvo Pharms Drug List
Given below is the complete list of Nuvo Pharms's drugs and the patents protecting them.
1. Nuvigil
Nuvigil is protected by 6 patents, out of which all have expired. Check out its patent list below.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US7132570
(Pediatric)
| Method for the production of crystalline forms and crystalline forms of optical enantiomers of modafinil |
18 Jun, 2024
(8 months ago)
| Expired |
US7297346
(Pediatric)
| Pharmaceutical formulations of modafinil |
29 May, 2024
(8 months ago)
| Expired |
US7132570 | Method for the production of crystalline forms and crystalline forms of optical enantiomers of modafinil |
18 Dec, 2023
(1 year, 2 months ago)
| Expired |
US7297346 | Pharmaceutical formulations of modafinil |
29 Nov, 2023
(1 year, 2 months ago)
| Expired |
USRE37516
(Pediatric)
| Acetamide derivative having defined particle size |
06 Apr, 2015
(9 years ago)
| Expired |
USRE37516 | Acetamide derivative having defined particle size |
06 Oct, 2014
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Nuvigil's drug page
2. Provigil
Provigil is protected by 4 patents, out of which all have expired. Check out its patent list below.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US7297346
(Pediatric)
| Pharmaceutical formulations of modafinil |
29 May, 2024
(8 months ago)
| Expired |
US7297346 | Pharmaceutical formulations of modafinil |
29 Nov, 2023
(1 year, 2 months ago)
| Expired |
USRE37516
(Pediatric)
| Acetamide derivative having defined particle size |
06 Apr, 2015
(9 years ago)
| Expired |
USRE37516 | Acetamide derivative having defined particle size |
06 Oct, 2014
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Provigil's drug page